Top Markets
Coin of the day
Voronoi, Inc. Voronoi, Inc.

Voronoi, Inc.

310210
Peringkat dalam Saham #6293
Voronoi, Inc., founded in 2015 and based in Incheon, South Korea, is a... Voronoi, Inc., founded in 2015 and based in Incheon, South Korea, is a biotechnology company dedicated to the research, development, and identification of small molecule kinase inhibitors. Its extensive product pipeline addresses various medical needs. Key candidates include VRN01, an oral leucine-rich repeat kinase 2 (LRRK2) inhibitor, being developed for glioblastoma multiforme, brain cancer, and pancreatic cancer. Treatments for lung cancer are represented by VRN07, VRN06, and VRN11, while VRN08 and VRN10 are in development for breast cancer. Additionally, VRN02 targets rheumatoid arthritis and atopic dermatitis. The company's pipeline further encompasses VRN04-1 for autoimmune conditions, VRN04-2 for multiple sclerosis and amyotrophic lateral sclerosis (ALS), VRN13 for pulmonary arterial hypertension, and VRN14 for challenging solid tumors.
Harga Saham
$115.48
Kapitalisasi Pasar
$2.12B
Perubahan (1 hari)
0.72%
Perubahan (1 tahun)
29.38%
Negara
KR
Perdagangan Voronoi, Inc. (310210)

Kategori

Riwayat hasil dividen untuk Voronoi, Inc. (310210)
Hasil dividen (TTM) dari Voronoi, Inc. (simbol saham: 310210) per 2026: 0
Rata-rata hasil dividen selama 5 tahun terakhir: 0.00%
Riwayat hasil dividen untuk Voronoi, Inc. (310210) dari 2026 hingga 2026
Hasil dividen pada akhir setiap tahun (TTM)
Tahun Hasil Dividen Mengubah
Tidak cukup data untuk tanggal yang disediakan.
Hasil dividen (TTM) untuk perusahaan serupa atau pesaing
Perusahaan Hasil Dividen Negara
0.00%
US
0.00%
NL
3.12%
AU
0.00%
US
0.00%
CH